US equities |
SPCX $166.97 ▲+5.04% NVDA $237.15 ▲+1.37% MU $1,065.20 ▼-0.90% TSLA $377.20 ▲+1.78% MSFT $525.43 ▲+1.53% INTC $116.50 ▼-2.37% SNDK $1,713.53 ▼-0.38% META $745.64 ▲+2.41%
FinancialContent

Articles published by SK pharmteco Inc.

News headline image
SK pharmteco Announces $200-Plus Million U.S. Investment to Expand Small Molecule and Peptide Capacity
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco Launches Catalyst Kit to Streamline Catalytic Reaction Development and Continuous Manufacturing Scale-Up
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco and GEMMABio Expand Rare Disease Manufacturing Collaboration Following Important Spinal Muscular Atrophy (SMA) Clinical Trial Milestone
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco to Attend CPHI, Showcasing Multimodal CDMO Capabilities and Global Manufacturing Infrastructure
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco Marks Construction Progress with Ribbon Cutting for Two Advanced Manufacturing Facilities at Swords, Ireland Campus
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco and Genethon Showcase French Manufacturing Strength Behind Pivotal DMD Gene Therapy Program
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco Announces SKyvec™, A Unified, High-Yield Viral Vector Platform Designed to Accelerate Gene Therapy Development from Batch to Bedside
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco Announces Strategic Collaboration with Orphan Therapeutics Accelerator for the Development and Manufacturing of Rare Disease Therapies
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco Collaborates with Axle Informatics and the National Institutes of Health to Advance Rare Disease Gene Therapy Programs
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco Achieves SBTi Validation for 2040 Net-Zero Science-Based Targets
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco to Host Innovations in Pharmaceutical Manufacturing Symposium in Cambridge, Massachusetts
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco and Prozomix Announce Strategic Collaboration to Enhance Biocatalysis Capabilities for Global Drug Manufacturing
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco Reaffirms Three-Business-Unit Strategy, Strengthens Global Gene Therapy Business Unit with Funding Commitment
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco Announces Successful FDA Inspection of Small Molecule Manufacturing Facility in La Porte, Texas
From SK pharmteco Inc.
Via GlobeNewswire
News headline image
SK pharmteco Announces CGMP Qualification of its Commercial-Scale Viral Vector Manufacturing Facility in France
From SK pharmteco Inc.
Via GlobeNewswire